SMi Group Ltd.

Join SMi Group in January 2013 London to discover the latest developments in compound screening and toxicity testing to companion diagnostic assays at our 6th annual Biomarkers Summit.

SMi’s 15th annual Superbugs and Superdrugs event held on 4th & 5th March in London will focus on combating multidrug resistance, R&D regulations and implementing public and private partnerships.

With clinical application and Innovation as the key theme throughout the industry, Imaging in Cancer Drug Development taking place in London, March 2013, focuses on current developments surrounding oncology imaging

SMi’s 12th annual conference on Drug Design taking place on the 18th & 19th February 2013 in London will provide attendees with an unparalleled opportunity for debate and problem solving of key challenges currently facing the field.

This unique conference will provide an unparalleled opportunity for debate and problem solving of key challenges currently facing the field, allowing attendees to discuss progress in the area and exchange ideas moving forward

In pharmaceutical storage and transportation, freeze-drying has been proven an essential method for pharmaceutical companies to distribute and store their products effectively, efficiently and inexpensively.

SMi’s inaugural Diabetes, Cardiovascular & Renal Complications conference will be held on 28th & 29th November in London is the perfect forum to assess the changing spectrum of therapies in development for treating diabetes.

SMi’s 7th annual Cold Chain Distribution conference will take place on the 3rd & 4th December London is Europe’s leading event and will provide attendees the chance to network with industry professionals at the forefront of innovation.

This conference will allow for key leaders in social media, communications, e-marketing and market research, to meet and discuss the innovations in social media, and the ways to approach each new and emerging field.

COPD: Novel Therapeutics & Management Strategies conference held on the 22nd & 23rd October in London will address therapeutic and management strategies for COPD with an international mix of key opinion leaders in this ever expanding field.